Summary of adverse effects in GCA/TAA pts treated with biological agents.

Abbreviations: A/E (adverse effects), TCZ (tocilizumab), IFX (infliximab), ETN (etanercept), ADA (adalimumab), RXB (rituximab), N (nausea), V (vomiting), N/A (not applicable), NR (not reported), HTN (hypertension), MI (myocardial infarction).* Cessation rate - discontinuation secondary to adverse effects;** Likely an overestimation as one study did not specify which patients developed leukopenia and transaminitisSummary of adverse effects in GCA/TAA pts treated with biological agents.